Literature DB >> 21784853

Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.

Amitabha Chaudhuri1, Ming-Hong Xie, Becky Yang, Kaushiki Mahapatra, Jinfeng Liu, Scot Marsters, Sweta Bodepudi, Avi Ashkenazi.   

Abstract

Although the signal transduction mechanisms of the receptor tyrosine kinase MET are well defined, less is known about its close relative RON. MET initiates intracellular signaling by autophosphorylation on specific cytoplasmic tyrosines that form docking sites for the adaptor proteins Grb2 and Gab1. Grb2 binds directly and is essential for all of the biological activities of MET. Gab1 docks either directly or indirectly via Grb2 and controls only a subset of MET functions. Because MET and RON possess similar adaptor binding sites, it was anticipated that their adaptor interactions would be conserved. Here we show that in contrast to MET, RON relies primarily on Gab1 for signal transmission. Surprisingly, disruption of the Grb2 docking site of RON or Grb2 depletion augments activity, whereas enhancement of Grb2 binding attenuates Gab1 recruitment and signaling. Hence, RON and MET differ in their adaptor interactions; furthermore, Grb2 performs a novel antagonistic role in the context of RON signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784853      PMCID: PMC3173233          DOI: 10.1074/jbc.M111.239384

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway.

Authors:  Marie Dance; Alexandra Montagner; Jean-Pierre Salles; Armelle Yart; Patrick Raynal
Journal:  Cell Signal       Date:  2007-10-11       Impact factor: 4.315

2.  Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo.

Authors:  Ute Schaeper; Regina Vogel; Jolanta Chmielowiec; Joerg Huelsken; Marta Rosario; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

3.  Cancer: drivers and passengers.

Authors:  Daniel A Haber; Jeff Settleman
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

4.  Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops.

Authors:  Anatoly Kiyatkin; Edita Aksamitiene; Nick I Markevich; Nikolay M Borisov; Jan B Hoek; Boris N Kholodenko
Journal:  J Biol Chem       Date:  2006-05-09       Impact factor: 5.157

5.  Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction.

Authors:  Cristina M Furdui; Erin D Lew; Joseph Schlessinger; Karen S Anderson
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

Review 6.  Epidermal growth factor receptor mutations in lung cancer.

Authors:  Sreenath V Sharma; Daphne W Bell; Jeffrey Settleman; Daniel A Haber
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

Review 7.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.

Authors:  D M Owens; S M Keyse
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

8.  Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation.

Authors:  Asuka Kondo; Naoki Hirayama; Yasuko Sugito; Michihiro Shono; Toshiaki Tanaka; Naomi Kitamura
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

Review 9.  Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.

Authors:  Itaru Matsumura; Masao Mizuki; Yuzuru Kanakura
Journal:  Cancer Sci       Date:  2008-01-02       Impact factor: 6.716

10.  The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway.

Authors:  Dawn R Mattoon; Betty Lamothe; Irit Lax; Joseph Schlessinger
Journal:  BMC Biol       Date:  2004-11-18       Impact factor: 7.431

View more
  16 in total

1.  Bivalent binding drives the formation of the Grb2-Gab1 signaling complex in a noncooperative manner.

Authors:  Caleb B McDonald; Vikas Bhat; David C Mikles; Brian J Deegan; Kenneth L Seldeen; Amjad Farooq
Journal:  FEBS J       Date:  2012-05-09       Impact factor: 5.542

Review 2.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

3.  Allostery mediates ligand binding to Grb2 adaptor in a mutually exclusive manner.

Authors:  Caleb B McDonald; Jimmy El Hokayem; Nawal Zafar; Jordan E Balke; Vikas Bhat; David C Mikles; Brian J Deegan; Kenneth L Seldeen; Amjad Farooq
Journal:  J Mol Recognit       Date:  2013-02       Impact factor: 2.137

4.  MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.

Authors:  Tom T Chen; Ellen Filvaroff; Jing Peng; Scot Marsters; Adrian Jubb; Hartmut Koeppen; Mark Merchant; Avi Ashkenazi
Journal:  EBioMedicine       Date:  2015-03-28       Impact factor: 8.143

Review 5.  Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets.

Authors:  Katherine Chang; Anand Karnad; Shujie Zhao; James W Freeman
Journal:  Oncotarget       Date:  2015-02-28

6.  Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.

Authors:  Steven E Kauder; Lydia Santell; Elaine Mai; Lilyan Y Wright; Elizabeth Luis; Elsa N N'Diaye; Jeff Lutman; Navneet Ratti; Susan M Sa; Henry R Maun; Eric Stefanich; Lino C Gonzalez; Robert R Graham; Lauri Diehl; William A Faubion; Mary E Keir; Judy Young; Amitabha Chaudhuri; Robert A Lazarus; Jackson G Egen
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

7.  Targeting the HGF-cMET Axis in Hepatocellular Carcinoma.

Authors:  Neeta K Venepalli; Laura Goff
Journal:  Int J Hepatol       Date:  2013-03-31

8.  Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages.

Authors:  Amitabha Chaudhuri; Nicholas S Wilson; Becky Yang; Andres Paler Martinez; Jinfeng Liu; Catherine Zhu; Nicole Bricker; Suzana Couto; Zora Modrusan; Dorothy French; James Cupp; Avi Ashkenazi
Journal:  Immunol Cell Biol       Date:  2013-07-02       Impact factor: 5.126

Review 9.  Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction.

Authors:  Ming-Hai Wang; Ruiwen Zhang; Yong-Qing Zhou; Hang-Ping Yao
Journal:  J Biomed Res       Date:  2013-07-30

10.  Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.

Authors:  D W Murray; S Didier; A Chan; V Paulino; L Van Aelst; R Ruggieri; N L Tran; A T Byrne; M Symons
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.